ARCHIVES

Drugs and Targets: EU approves Imbruvica in MCL, CLL

This article is from The Cancer Letter archive.

Vol. 40 No. 40 | October 24, 2014

Download PDF Visit The Full Archive

Related Articles

Program Announcement On Effects Of Low Dose Radiation

October 2, 1981

BioSeek Awarded NIH SBIR For Compound Validation.

July 4, 2003

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

November 28, 2014

Other DCT Concepts Approved By BSC

June 6, 1986

Voluntary Organizations: Myles Cunningham elected ACS President

November 8, 1996

New CREG Announcements Made By NCI

October 3, 1975